Академический Документы
Профессиональный Документы
Культура Документы
Definition
Pathologic process characterized by
dysregulated cell growth and spread
All tissue types have neoplastic potential and
can become cancerous. The ff. have higher
rates of malignancy:
Tissues distinguished by rapid cell turnover (GI
mucosa)
Tissues with high hormone sensitivity (breast,
prostate)
Tissues with regular exposure to environmental
mutagens (lung, skin)
Definition
Differentiation
Process by which normal cells undergo physical and
structural changes as they develop to form
different tissues of the body
In malignant cells, differentiation is altered and
may be lost completely so that the malignant cell
may not be recognizable in relationship to its
parent cell
When tumor has completely lost identity, it is
considered to be undifferentiated (aplastic)
The less differentiated a tumor becomes, the faster
the metastasis
Definition
Dysplasia
General category which indicates a
disorganization of cells in which an adult
cell varies from its normal size, shape or
organization
Definition
Metaplasia
First level of dysplasia (early dysplasia)
Reversible and benign but abnormal
change in which one adult cell changes
from one type to another
Definition
Anaplasia
Most advance form of metaplasia and is
characteristic of malignant cells only
Definition
Hyperplasia
Increase in the number of cells in tissue,
resulting in increased tissue mass
Can be normal
Neoplastic Hyperplasia increase in cell
mass because of tumor formation and is
abnormal
Definition
Tumors
Or neoplasms
Abnormal growths of tissue that serve
no useful purpose and may harm the
host organism by competing for vital
blood supply and nutrients
May be benign or malignant
May be primary or secondary
Definition
Tumors
Benign usually considered harmless
and does not spread to or invade other
tissues
Malignant the more dangerous kind
Definition
Tumors
Primary tumor
Cells that are normally local to the given
structure
Secondary tumor
Arises from cells that have metastasized
from another part of the body
Epidemiology
Prevalent condition that becomes
increasingly common with advanced
age
Over 1,300,000 new cancers were
diagnosed within the USA in 2004
Over 500,000 people died of CA
CA causes 1 in 4 deaths
2nd to heart disease as the leading cause
of mortality in developed countries
Epidemiology
Roughly 76% of all CA occur in patients 55
years of age and older
Men > female (excluding basal and
squamous cell cancers of the skin)
Lifetime risk in men: 1 in 2
Lifetime risk in women: 1 in 3
In 2004, the American Cancer Society
estimated that 180,000 CA deaths are
related to obesity, physical inactivity, and
other lifestyle factors
Epidemiology
Only 5-10% of CA are hereditary and
directly related to aberrantly
expressed or regulated genes
MC CA showing familial pattern
include prostate, breast, ovarian and
colon cancer
Epidemiology
Men = MC CA are predicted to be CA
of prostate, lung and bronchus, and
colon/rectum
Women = CA of breast, lung and
bronchus, and colon/rectum
Without gender bias = lung and
bronchus
Demographic Disparities in CA
African Americans have the highest
mortality asso. c CA of lungs, breast,
prostate, and cervix among all racial
groups in the USA
When African Americans are
compared with whites, CA death
rates are 40% higher in males and
20% higher in females
Demographic Disparities in CA
A report in 2003 by the Institute of
Medicine identified poverty as the
most critical overall factor affecting
health and longevity
The 5-year survival rate is over 10%
higher for individuals living in
affluent census tracts
Etiology
Endogenous (genetic)
Exogenous (environmental or
external)
Most CA develop as a result of multiple
environmental, viral and genetic factors
working together to disrupt immune
system along with failure of an aging
immune system to recognize and
scavenge cells that have become less
differentiated
Etiology
Carcinogens
Etiologic agent capable of initiating the
malignant transformation of a cell
Viruses
HIV
Chemical Agents
Tar, soot, asphalt, dyes, hydrocarbons,
oils, nickel or arsenics
Etiology
Physical agents
Radiation or asbestos
Drugs
Cancer chemotherapeutic agents are in
themselves carcinogenic
Cytotoxic drugs including steroids
(decrease antibody production and
destroy circulating lymphocytes
Etiology
Hormones
Have been linked to tumor development
and growth (estrogen = stimulating the
growth of the endometrial lining, which
overtime becomes anaplastic)
Excessive alcohol
Associated with cancer of mouth,
pharynx, larynx, esophagus, pancreas
Etiology
Diet as an influence to the risk of CA
The National Research Council
recommends a diet in total saturated
fat, a high in complex carbohydrates
and fiber, low in sugars and
moderate in protein especially
animal proteins.
Etiology
High intake of fats = linked to breast, colon
and prostate CA
Low intake of fruits, vegetables, complex
carbs and fiber = colon, larynx, esophagus,
prostate, bladder, stomach and lungs
Salt-cured foods = may influence CA of
esophagus and stomach
Obesity = linked to CA of breast, colon,
uterus, and gallbladder
Psychological factors = chronic stress
Risk Factors
Pathophysiology
Metastasis = transfer of diseased
cells of one organ to another or part
of another not directly connected
with it
Because cells are not encapsulated,
it is easy for CA cells to invade other
tissues and extend themselves
rapidly via lymphatic and blood
circulatory systems
Pathophysiology
Lymph secondary growths of tumor
cells are often caught in the lymph
filter, the lymph node
In the blood = by invasion, tumor
cells enter the blood vessels and are
carried to organs where the venous
blood passes through the capillary
bed
Classification
Classification of Neoplasm
Epithelial
Covers all external body surfaces and lines
all internal spaces and cavities
Cacinoma
From glandular epithelium
Adenocarcinoma
Classification
Classification of Neoplasm
Connective Tissue
Elastic fibrous and collagenous tissues
(bone, cartilage, etc.)
Sarcomas
If from nerve tissue, CA is named for the
type of cell involved (e.g. astrocytoma =
astrocytes)
Classification
Classification of Neoplasm
Lymphoid tissues
Lymphomas
Hematopoietic
Leukemia, multiple myeloma,
myelodysplasia
Classification
Staging and Grading
Stage 0 Carcinoma in situ
(premalignant, pre invasive)
Stage I Early stage; local cancer
Stage II Increased risk of spread
because of tumor size
Stage III Local cancer has spread but
may not be disseminated to distant
regions
Stage IV Cancer has spread and
disseminated to distant sites
Prognosis
It is clear that some tumors notably
esophagus, stomach, hepatic,
pancreas, lungs, nervous system and
leukemias/ myeloma have a low
five year survival rate
Others breast, larynx, prostate, and
kidney, among others have a much
better prognosis.
Survivorship
Cancer 5 yr survival rates are
increasingly due to:
Successful early detection efforts
Improved multimodality treatments
Expansion of chemotherapeutics
available
Survivorship
Prevalence will increase due to the ff factors:
Aging of the population will produce an increase
in the incidence of age-related CA such as colon,
breast, and prostate CA
Early detection efforts are being aggressively
funded and implemented. We can expect that
more and more CA will be identified at early,
curable stages.
Clinical research continues to refine strategies for
delivering established and novel anticancer
therapies
Clinical Manifestations
Clinical manifestations
The therapist is most likely to
observe signs and symptoms
affecting one of the ff. systems:
Integumentary
Pulmonary
Neurologic
Musculoskeletal
Hepatic
Clinical manifestations
Proximal Muscle Weakness
If idiopathic may be an early sign of
cancer
Known as carcinomatous
neuromyopathy
May occur secondary to hypercalcemia
indirect effect on bone
Clinical manifestations
Pain
Rarely an early warning
Night pain that is constant and intense
= red flag symptom of cancer
Result of destruction of tissue or
pressure on tissue
Clinical manifestations
Change in One or More Deep Tendon
Reflexes
May be hyperreflexive or hyporeflexive,
depending on which level the tumor has
impinged the reflex arc
Clinical manifestations
Integumentary
Often present as asymmetrical, firm,
skin-colored, red, purple, or blue
nodules near the primary tumor
Scalp = alopecia neoplastica
Clinical manifestations
Pulmonary
Pleural pain and dyspnea = first 2
symptoms
Clinical manifestations
Neurologic manifestations
Headachev(30-50%; usually bioccipital
or bifrontal)
Personality change
Seizures (1/3 of persons with metastatic
brain tumor)
Papilledema (edema and hyperemia of
the optic disc) may be the first sign of
intracranial tumors
CTS
Clinical manifestations
Neurologic manifestations
Nerve and Cord compression
Clinical manifestations
Musculoskeletal
Bone pain
Fracture
Back pain
Hepatic Manifestations
Diagnosis
Tissue Biopsy
Taking of a tissue sample
An important diagnostic tool in the study of
tumors
Tumor Markers
Substances produced and secreted by tumor
cells
May be found in the blood serum
The level of tumor markers is not a diagnostic
tool itself but can signal malignancies and the
extent of the disease
Diagnosis
MRI
Procedure of choice to evaluate the
epidural space and SC
CT Scan
If there is absolute contraindication to
MRI
Best for evaluation of spinal roots
Electromyography
When nerves are involved
Narcotic Analgesics
Bind to opiate receptors and act on the CNS
pathways
Adjuvant Analgesics
Enhance the narcotic analgesics effect or act
independently and provide analgesia
Intraspinal Opiates
Complications
Septic Shock
Spinal Cord Compression
Hypercalcemia
Superior Vena Cava Syndrome
(Obstruction)
Complications
Side effects of CA Treatment
Refer to the table found in Pathology
Implications for the Physical Therapist
by Goodman and Fuller
PT Assessment
Observation
Inspection
Auscultation
Percussion
Palpation
Special tests
PT Management
Cancer Rehabilitation
Addresses physical impairments related
to tumor effects or to cancer treatment
The fact that any tissue can develop
cancer means that cancer rehab must
address all body parts and systems
Extends far beyond efforts to decelerate
the functional decline in patients with
metastatic disease
PT Management
General Strategies
Exercise
Aerobic conditioning
Resistive exercise
Rehabilitation of cardiopulmonary
dysfunction
Flexibility exercises
Lymphedema Management
PT Management
Specific CA populations
Breast CA
Head and Neck CA
END